These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 1965508

  • 21. A brief intensive cisplatin-based outpatient chemotherapy regimen with filgrastim and megestrol acetate support for advanced non-small cell lung cancer: results of a phase II trial.
    Levitan N, Dowlati A, Craffey M, Tahsildar H, MacKay W, McKenney J, Remick SC.
    Lung Cancer; 1998 Dec; 22(3):227-34. PubMed ID: 10048475
    [Abstract] [Full Text] [Related]

  • 22. Evaluation of cisplatin, carboplatin, and etoposide in metastatic nonsmall cell lung carcinoma. A phase II study of the Southwest Oncology Group.
    Figlin RA, Crowley JJ, Jacobs EL, Muirhead M, Goodwin JW, Rinehart JJ, Livingston RB.
    Cancer; 1996 Sep 01; 78(5):998-1003. PubMed ID: 8780537
    [Abstract] [Full Text] [Related]

  • 23. Chemotherapy with 5-fluorouracil (5-FU) and cisplatin or 5-FU, cisplatin, and vinblastine for advanced non-small cell lung cancer. A randomized phase II study of the cancer and leukemia group B.
    Richards F, Perry DJ, Goutsou M, Modeas C, Muchmore E, Rege V, Chahinian AP, Hirsh V, Poiesz B, Green MR.
    Cancer; 1991 Jun 15; 67(12):2974-9. PubMed ID: 1646066
    [Abstract] [Full Text] [Related]

  • 24. A phase II trial of concurrent chemoradiation therapy followed by consolidation chemotherapy with oral etoposide and cisplatin for locally advanced inoperable non-small cell lung cancers.
    Park J, Ahn YC, Kim H, Lee SH, Park SH, Lee KE, Lim DH, Park J, Kim K, Jung CW, Im YH, Kang WK, Lee MH, Park K.
    Lung Cancer; 2003 Nov 15; 42(2):227-35. PubMed ID: 14568691
    [Abstract] [Full Text] [Related]

  • 25. Trial of vindesine, etoposide, and cisplatin in patients with previously treated, advanced-stage, non-small cell bronchogenic carcinoma.
    Albain KS, Bitran JD, Golomb HM, Hoffman PC, DeMeester TR, Skosey C, Noble S, Blough RR.
    Cancer Treat Rep; 1984 Feb 15; 68(2):413-5. PubMed ID: 6538114
    [Abstract] [Full Text] [Related]

  • 26. A randomized trial of two platinum combinations in patients with advanced non-small cell lung cancer: a preliminary report. European Organization for the Research and Treatment of Cancer--Lung Cancer Working Party.
    Klastersky J, Sculier JP, Dabouis G, Bureau G, Libert P, Ravez P, Vandermoten G, Thiriaux J, Lecomte J, Cordier R.
    Semin Oncol; 1990 Feb 15; 17(1 Suppl 2):20-4. PubMed ID: 2154855
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Cisplatin/carboplatin + etoposide + vinorelbine in advanced non-small-cell lung cancer: a multicentre randomised trial. Gruppo Oncologico Campano.
    Comella P, Frasci G, De Cataldis G, Panza N, Cioffi R, Curcio C, Belli M, Bianco A, Ianniello G, Maiorino L, Della Vittoria M, Perchard J, Comella G.
    Br J Cancer; 1996 Dec 15; 74(11):1805-11. PubMed ID: 8956797
    [Abstract] [Full Text] [Related]

  • 30. Etoposide and mitomycin in the treatment of non-small-cell lung cancer. A phase I-II evaluation.
    Ettinger DS, Bitran JD, Comis RL, Langer CJ, Harwood KV, Harris CL, Keller JH, Losada M.
    Am J Clin Oncol; 1991 Apr 15; 14(2):127-32. PubMed ID: 1851388
    [Abstract] [Full Text] [Related]

  • 31. A phase II study of methotrexate, doxorubicin, cyclophosphamide, and lomustine chemotherapy and lonidamine in advanced non-small cell lung cancer.
    Buccheri G, Ferrigno D, Rosso A.
    Cancer; 1993 Sep 01; 72(5):1564-72. PubMed ID: 8394198
    [Abstract] [Full Text] [Related]

  • 32. Alternated approach with local irradiation and combination chemotherapy including cisplatin or carboplatin plus epirubicin and etoposide in intermediate stage non-small cell lung cancer.
    Comella P, Scoppa G, Daponte A, Musetta G, Anania C, Maiorino A, Curcio C, Casaretti R, Comella G.
    Cancer; 1994 Oct 01; 74(7):1874-81. PubMed ID: 8082093
    [Abstract] [Full Text] [Related]

  • 33. [Cytostatic treatment of patients with advanced non-small cell lung cancer].
    Zych J, Radzikowska E, Załeska J, Obłakowski P, Słodkowska J, Rowińska-Zakrzewska E.
    Pneumonol Alergol Pol; 1998 Oct 01; 66(1-2):73-8. PubMed ID: 9658884
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Pilot study with cisplatin, ifosfamide, and etoposide in advanced non-small-cell lung carcinoma.
    Bidoli P, Spinazzè S, Santoro A, Casali P, Bedini AV, Guzzon A.
    Am J Clin Oncol; 1990 Oct 01; 13(5):424-6. PubMed ID: 2171319
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. A randomized phase II study of ifosfamide/mesna/cisplatin plus G-CSF or etoposide/cisplatin plus G-CSF in advanced non-small cell lung cancer: a Cancer and Leukemia Group B study.
    Graziano SL, Valone FH, Herndon JE, Crawford J, Richards F, Rege VB, Clamon G, Green MR.
    Lung Cancer; 1996 Jun 01; 14(2-3):315-29. PubMed ID: 8794413
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.